Creswell Paul D, McCarthy Danielle E, Trapskin Philip, Sheehy Ann, Skora Amy, Adsit Robert T, Zehner Mark E, Baker Timothy B, Fiore Michael C
UW Center for Tobacco Research and Intervention (UW-CTRI), University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
UW Health, University of Wisconsin School of Pharmacy, Madison, WI, USA.
Am J Health Syst Pharm. 2022 Jun 7;79(12):969-978. doi: 10.1093/ajhp/zxab488.
Hospitalization affords an opportunity to reduce smoking, but fewer than half of patients who smoke receive evidence-based cessation treatment during inpatient stays. This study evaluated a pharmacist-led, electronic health record (EHR)-facilitated opt-out smoking cessation intervention designed to address this need.
Analyses of EHR records for adult patients who smoked in the past 30 days admitted to an academic medical center in the upper Midwest were conducted using the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) framework. The reach of a pharmacist-led, EHR-facilitated protocol for smoking cessation treatment was assessed by comparing patients' receipt of nicotine replacement therapy (NRT) and tobacco quitline referral before and after implementation. χ2 tests, t tests, and multiple logistic regression models were used to compare reach across patient demographic groups to assess treatment disparities and the representativeness of reach. Adoption of the program by hospital services was also assessed.
Of the 70 hospital services invited to implement the program, 88.6% adopted it and 78.6% had eligible admissions. Treatment reach increased as rates of delivering NRT rose from 43.6% of eligible patients before implementation to 50.4% after implementation (P < 0.0001) and quitline referral rates rose from 0.9% to 11.9% (P < 0.0001). Representativeness of reach by sex and ethnicity improved after implementation, although disparities by race and age persisted after adjustment for demographics, insurance, and primary diagnosis. Pharmacists addressed tobacco use for eligible patients in 62.5% of cases after protocol implementation.
Smoking cessation treatment reach and representativeness of reach improved after implementation of a proactive, pharmacist-led, EHR-facilitated opt-out smoking cessation treatment protocol in adult inpatient services.
住院治疗为戒烟提供了契机,但住院期间接受循证戒烟治疗的吸烟患者不到半数。本研究评估了一项由药剂师主导、电子健康记录(EHR)辅助的退出式戒烟干预措施,以满足这一需求。
采用“覆盖、效果、采纳、实施、维持”(RE-AIM)框架,对美国中西部上游地区一家学术医疗中心收治的过去30天内吸烟的成年患者的EHR记录进行分析。通过比较实施前后患者接受尼古丁替代疗法(NRT)和戒烟热线转诊的情况,评估由药剂师主导、EHR辅助的戒烟治疗方案的覆盖范围。使用χ²检验、t检验和多元逻辑回归模型比较不同患者人口统计学组的覆盖范围,以评估治疗差异和覆盖范围的代表性。还评估了医院各科室对该项目的采纳情况。
在受邀实施该项目的70个医院科室中,88.6%采纳了该项目,78.6%有符合条件的入院患者。随着NRT给药率从实施前符合条件患者的43.6%升至实施后的50.4%(P<0.0001),以及戒烟热线转诊率从0.9%升至11.9%(P<0.0001),治疗覆盖范围有所增加。实施后,按性别和种族划分的覆盖范围代表性有所改善,尽管在对人口统计学、保险和主要诊断进行调整后,种族和年龄差异仍然存在。在方案实施后,药剂师在62.5%的病例中为符合条件的患者解决了烟草使用问题。
在成人住院服务中实施一项积极主动、由药剂师主导、EHR辅助的退出式戒烟治疗方案后,戒烟治疗的覆盖范围和覆盖范围的代表性得到了改善。